CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BridgeBio Oncology Therapeutics, Inc.
Sign in to watch- Ticker
- BBOT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857 702 0377
- Business address
- 256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Helix Acquisition Corp. II
- 4 Shares withheld for taxes President and CEO gave up 1,047 shares (to pay taxes)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Other disposition Director disposed of 4,528,186 shares (other)
- 424B3 Offering Prospectus
- 8-K Event Executive or director change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- 4 Shares withheld for taxes Chief Med & Dev Officer gave up 1,047 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,047 shares (to pay taxes)
Page 2 of 10 · 187 filings